Robert Yarchoan Selected Research

Kaposi Sarcoma (Kaposi's Sarcoma)

3/2022	Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection.
1/2022	Immunotherapy for KSHV-associated diseases.
1/2021	Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders.
1/2021	Characterizing Expression and Regulation of Gamma-Herpesviral Circular RNAs.
1/2021	Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2.
1/2020	Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
1/2020	Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA.
1/2019	A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma.
12/2018	Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
11/2018	Polymorphisms in KSHV-encoded microRNA sequences affect levels of mature viral microRNA in Kaposi Sarcoma lesions.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert Yarchoan Research Topics

Disease

37	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2022 - 03/2002
33	Neoplasms (Cancer) 01/2022 - 01/2003
17	Infections 01/2021 - 03/2002
13	Acquired Immunodeficiency Syndrome (AIDS) 08/2021 - 06/2003
11	Primary Effusion Lymphoma 01/2022 - 03/2007
11	Castleman Disease (Castleman's Disease) 01/2022 - 03/2007
7	Hypoxia (Hypoxemia) 01/2017 - 06/2003
6	Lymphoma (Lymphomas) 01/2021 - 06/2003
6	Multi-centric Castleman's Disease 01/2021 - 12/2014
4	HIV Infections (HIV Infection) 03/2022 - 11/2006
4	Neutropenia 01/2019 - 06/2006
4	Virus Diseases (Viral Diseases) 12/2018 - 07/2011
3	COVID-19 01/2021 - 01/2020
3	Hypoalbuminemia 01/2019 - 08/2010
3	Hypertension (High Blood Pressure) 01/2019 - 07/2010
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019 - 04/2010
3	Hyponatremia 12/2013 - 08/2010
2	Viremia 01/2022 - 12/2016
2	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2017
2	Immune Reconstitution Inflammatory Syndrome 10/2018 - 04/2015
2	Prostatic Neoplasms (Prostate Cancer) 04/2012 - 07/2010
2	Fever (Fevers) 01/2012 - 08/2010
2	Cytopenia 01/2012 - 08/2010
2	Opportunistic Infections (Opportunistic Infection) 04/2010 - 07/2006
2	AIDS-related Kaposi sarcoma 12/2007 - 06/2006
2	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 07/2006 - 08/2005
1	Breast Neoplasms (Breast Cancer) 01/2022
1	T-Cell Leukemia (Leukemia, T Cell) 01/2022
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021
1	Drug-Related Side Effects and Adverse Reactions 10/2020
1	Oral Manifestations 01/2020
1	Hypothyroidism 09/2019
1	Pneumonia (Pneumonitis) 09/2019
1	Autoimmune Diseases (Autoimmune Disease) 09/2019
1	Exanthema (Rash) 09/2019
1	Hepatitis B 09/2019
1	Gastrointestinal Hemorrhage (Hematochezia) 01/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	WHIM syndrome 12/2018
1	Epidermodysplasia Verruciformis 12/2018

Drug/Important Bio-Agent (IBA)

12	CytokinesIBA 01/2022 - 01/2012
8	pomalidomideIBA 03/2022 - 04/2014
7	MicroRNAs (MicroRNA)IBA 11/2018 - 03/2007
5	Pharmaceutical PreparationsIBA 01/2021 - 01/2003
5	Rituximab (Mabthera)FDA Link 11/2020 - 04/2010
5	Interleukin-6 (Interleukin 6)IBA 01/2019 - 08/2010
5	liposomal doxorubicin (Doxil)FDA Link 01/2019 - 01/2007
4	Antiviral Agents (Antivirals)IBA 01/2021 - 08/2005
4	AntigensIBA 08/2017 - 06/2010
4	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 07/2010
3	pembrolizumabIBA 01/2022 - 09/2019
3	Bevacizumab (Avastin)FDA Link 01/2019 - 07/2010
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2012
3	Zidovudine (Retrovir)FDA LinkGeneric 09/2012 - 07/2007
3	Interleukin-12 (IL 12)IBA 12/2007 - 06/2006
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2021 - 08/2017
2	Circular RNAIBA 01/2021 - 12/2018
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2020
2	remdesivirIBA 01/2021 - 01/2020
2	LigandsIBA 10/2020 - 09/2019
2	Monoclonal AntibodiesIBA 10/2020 - 09/2012
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2003
2	Transaminases (Aminotransferases)IBA 09/2019 - 06/2006
2	Interleukin-10 (Interleukin 10)IBA 01/2019 - 12/2013
2	InterleukinsIBA 01/2019 - 08/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2018 - 03/2002
2	Lenalidomide (CC 5013)FDA Link 08/2017 - 04/2014
2	endothelial PAS domain-containing protein 1IBA 01/2017 - 06/2003
2	Messenger RNA (mRNA)IBA 01/2017 - 01/2015
2	C-Reactive ProteinIBA 12/2013 - 01/2012
2	Valganciclovir FDA Link 09/2012 - 06/2011
2	BilirubinIBA 04/2012 - 06/2006
2	Peptides (Polypeptides)IBA 08/2010 - 03/2010
2	AntibodiesIBA 08/2010 - 06/2010
1	abemaciclibIBA 01/2022
1	CyclinsIBA 01/2022
1	InterferonsIBA 01/2022
1	ribociclibIBA 01/2022
1	palbociclibIBA 01/2022
1	Interleukin-13IBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 11/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	NucleotidesIBA 01/2020
1	indoleIBA 01/2020
1	tocilizumab (atlizumab)FDA Link 01/2020
1	EstersIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 09/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Circular DNAIBA 12/2018
1	plerixafor FDA Link 12/2018

Therapy/Procedure

38	Therapeutics 01/2022 - 01/2003
6	Highly Active Antiretroviral Therapy (HAART) 12/2007 - 05/2002
3	Immunotherapy 10/2020 - 08/2017
3	Art Therapy 09/2019 - 12/2016
3	Lasers (Laser) 01/2006 - 01/2004
2	Drug Therapy (Chemotherapy) 01/2021 - 12/2007
1	Intravenous Administration 01/2022